1. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final policy recommendations Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, May 11, 2021 Subject(s): ImmunoconjugatesImmunotherapy, AdoptiveMultiple MyelomaUnited States
